Literature DB >> 18849605

Mixed brain pathologies in dementia: the BrainNet Europe consortium experience.

Gabor G Kovacs1, Irina Alafuzoff, Safa Al-Sarraj, Thomas Arzberger, Nenad Bogdanovic, Sabina Capellari, Isidro Ferrer, Ellen Gelpi, Viktor Kövari, Hans Kretzschmar, Zoltan Nagy, Piero Parchi, Danielle Seilhean, Hilkka Soininen, Claire Troakes, Herbert Budka.   

Abstract

BACKGROUND: Dementia results from heterogeneous diseases of the brain. Mixed disease forms are increasingly recognized.
METHODS: We performed a survey within brain banks of BrainNet Europe to estimate the proportion of mixed disease forms underlying dementia and age- and gender-specific influences.
RESULTS: Data collected in 9 centres from 3,303 individuals were analysed. The proportion of patients with mixed diagnoses among all cases with Alzheimer disease (AD), vascular pathology (VP), argyrophilic grain dementia (AGD), and synucleinopathies, such as Lewy body dementia (LBD), Parkinson disease (PD) and synuclein pathology only in the amygdala, was 53.3%. Mixed pathology was more frequently reported with LBD, PD, AGD, and VP than with AD. The percentage of mixed diagnoses for AGD and VP significantly differed between centres. In patients younger than 75 years, synucleinopathies, and pure forms of AD, VP, and AGD were more frequent in men. Above 75 years of age, more women had pure AD and pure AGD.
CONCLUSIONS: The most obvious neuropathological alteration should not terminate the diagnostic procedure since copathology is likely to be found. Neuropathological interpretation of AGD and VP has not been sufficiently established in a consensus. Pure forms of synucleinopathies are unlikely sole substrates for dementia. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2008        PMID: 18849605     DOI: 10.1159/000161560

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  57 in total

Review 1.  The role of phytochemicals in the treatment and prevention of dementia.

Authors:  Melanie-Jayne R Howes; Elaine Perry
Journal:  Drugs Aging       Date:  2011-06-01       Impact factor: 3.923

Review 2.  Sharpening the boundaries of Parkinson-associated dementia: recommendation for a neuropsychological diagnostic procedure.

Authors:  Marc R Bothe; Ingo Uttner; Markus Otto
Journal:  J Neural Transm (Vienna)       Date:  2010-01-30       Impact factor: 3.575

Review 3.  Primary Age-Related Tauopathy (PART): Addressing the Spectrum of Neuronal Tauopathic Changes in the Aging Brain.

Authors:  Richard A Hickman; Xena E Flowers; Thomas Wisniewski
Journal:  Curr Neurol Neurosci Rep       Date:  2020-07-14       Impact factor: 5.081

Review 4.  [Retinal imaging of the macula and optic disc in neurodegenerative diseases].

Authors:  G N Turski; S Schmitz-Valckenberg; F G Holz; R P Finger
Journal:  Ophthalmologe       Date:  2017-02       Impact factor: 1.059

5.  Modulating protein amyloid aggregation with nanomaterials.

Authors:  Bo Wang; Emily H Pilkington; Yunxiang Sun; Thomas P Davis; Pu Chun Ke; Feng Ding
Journal:  Environ Sci Nano       Date:  2017-07-28

Review 6.  Challenges of multimorbidity of the aging brain: a critical update.

Authors:  Kurt A Jellinger; Johannes Attems
Journal:  J Neural Transm (Vienna)       Date:  2014-08-05       Impact factor: 3.575

7.  Residual decline in cognition after adjustment for common neuropathologic conditions.

Authors:  Lei Yu; Patricia A Boyle; Eisuke Segawa; Sue Leurgans; Julie A Schneider; Robert S Wilson; David A Bennett
Journal:  Neuropsychology       Date:  2014-12-15       Impact factor: 3.295

8.  Prominent psychiatric symptoms in patients with Parkinson's disease and concomitant argyrophilic grain disease.

Authors:  O Grau-Rivera; E Gelpi; M J Rey; F Valldeoriola; E Tolosa; Y Compta; M J Martí
Journal:  J Neurol       Date:  2013-09-18       Impact factor: 4.849

9.  Characterization of the Brain 26S Proteasome and its Interacting Proteins.

Authors:  Hwan-Ching Tai; Henrike Besche; Alfred L Goldberg; Erin M Schuman
Journal:  Front Mol Neurosci       Date:  2010-05-21       Impact factor: 5.639

Review 10.  Alzheimer's Disease-Related Dementias Summit 2016: National research priorities.

Authors:  Roderick A Corriveau; Walter J Koroshetz; Jordan T Gladman; Sophia Jeon; Debra Babcock; David A Bennett; S Thomas Carmichael; Susan L-J Dickinson; Dennis W Dickson; Marian Emr; Howard Fillit; Steven M Greenberg; Michael L Hutton; David S Knopman; Jennifer J Manly; Karen S Marder; Claudia S Moy; Creighton H Phelps; Paul A Scott; William W Seeley; Beth-Anne Sieber; Nina B Silverberg; Margaret L Sutherland; Angela Taylor; Christine L Torborg; Salina P Waddy; Amelie K Gubitz; David M Holtzman
Journal:  Neurology       Date:  2017-11-08       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.